glp-1 and mash Incretin-based therapies in MASLD/MASH: from receptor agonists to dual triple agonists What is becoming the #1
Description
DOI: 10.1038/s41366-026-02088-1,
Experts are skeptical
Think: Should I eat this
Our team is on the journey with you to ensure youre achieving your goals and most importantly, experiencing a healthier you
Applying a binomial GLM indicated a significant effect of estrogen level on nausea and vomiting rates (p=.002 for pre/post GLP1R agonist, and p=.004 for pre/post x estrogen range) To determine percent weight loss, weights were first cleaned according to Rodriguez et al., 2024
Connect with a weight loss healthcare provider through Klinic to receive a prescription
